Humana Appoints Christopher Kay as Chief Innovation Officer

LOUISVILLE, Ky.–()–Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, announced today that it has appointed Christopher Kay as Senior Vice President and Chief Innovation Officer, effective March 17. Kay will report to President and Chief Executive Officer Bruce Broussard and serve on the company’s Management Team.

In his new role, Kay will lead the company’s innovation strategy. Among other priorities, he will focus on innovations in personalized health designed to simplify the health care experience, leading to better health outcomes. Continue reading

Aetna and Medtronic Collaborate to Help Members Take Better Control of Type 2 Diabetes

HARTFORD, Conn. & MINNEAPOLIS–(BUSINESS WIRE)–Beginning this month, Aetna (NYSE: AET) and Medtronic, Inc. (NYSE: MDT) will work with doctors in a new program to reach up to 300 fully insured members with uncontrolled type 2 diabetes who may improve their health using insulin pump therapy. Eligible members will receive targeted education, case management and other patient support to help control blood sugar, which also may lower their health care costs. Information gathered from the program also is expected to help doctors and other health care providers more easily identify and support those who can benefit most from this therapy.

“We want to help members with type 2 diabetes to enjoy a more flexible lifestyle and have better glucose control. Improving education and assistance for those learning to use insulin pumps may help increase consideration and successful use of a proven therapy that can help them achieve these goals,” said Ed Pezalla, M.D., Aetna’s national medical director for pharmacy policy and strategy. “We also are excited to create value-based arrangements with companies like Medtronic who are ready to share accountability for the role their products and services play in improving members’ health.” Continue reading